Immediate effect of osteopatic manipulative treatment on pulmonary sequel in patients post COVID 19 - Controlled randomized clinical trial

Ana Paula Cochar0 个研究点开始时间: 2022年4月27日最近更新: 2023年5月29日

试验速览

暂无简介。

•Will be selected for this study, individuals between 18 and 60 years, both sexes, who had a positive diagnosis for COVID-19, confirmed by the RT-PCR test or who were diagnosed using clinical criteria associated with radiological image, computed tomography, D-dimer , presenting a picture compatible with COVID-19, hemodynamic stability and who presented a decrease in oxygen saturation. In addition, patients who did not progress to mechanical ventilatory support and who, after the active viral period, evolved with sequelae caused by the disease will be considered.

•Participants will be excluded from the study if they present lowered level of consciousness or who are unable to obey simple commands, acute decline in neurological status; hypotension (MAP less 60 mmHg) or hypertension (MAP up to 120 mmHg); tetany; continuous renal replacement therapy; Body Mass Index - BMI up to 30 kg/m2; previous thoracic surgery; chest instability; presence of chest tube; with complications from other serious underlying diseases, such as decompensated diabetes, obstructive and restrictive pulmonary disease, coronary heart disease, stroke with sequelae, fractures with sequelae, cancer, osteoporosis, immunodeficiency, fever, use of illicit drugs, congenital malformations, deformities, rejection of the treatment and any clinical alteration that makes the handling and execution of the technique unfeasible.

发起方

Ana Paula Cochar